The protein expression of ABCG2 and OAT1 in the kidney was increased, and the protein expression of GLUT9 and URAT1 was downregulated; these effects reduce serum uric acid concentration, thereby preventing the occurrence of hyperuricemia. The gene discussed is SLC22A12; the disease is hyperuricemia.